Skcin are grateful of the support we receive from business, charities and organisations that help us achieve our goals and make our visions a reality. From leading brands and retailers to charities and trusts - support is given in many ways. If you have a vision of how we can work collaboratively for the benefit of your stakeholder community, please get in touch.
SKCIN would like to pay special thanks to the David Price Melanoma Trust for funding the build of this website and their continued support of our diverse work. The David Price Melanoma Trust has supported SKCIN for over a decade, funding a number of projects and initiatives that have made our mission possible and our vision a reality. We are forever grateful for the guidance and support of their Trustees and the opportunity through our years of collaboration to create a long-standing legacy in memory of David Price.
About the David Price Melanoma Trust: Since its inception in 1988, the David Price Melanoma Trust has a history of giving in the field of Melanoma, supporting research at St Thomas’s and Westminster Hospitals, specialist health technology at Mount Vernon Hospital and sun safe awareness education initiatives in partnership with SKCIN and, previously, with Teenage Cancer Trust.
David was 34 when he died on 29th October 1988. David’s wife Alison Price said: “David was a much loved husband and adoring father of 2 very young children. Our daughter was 4 and our son had just had his first birthday when he died. My family and I have tried to fill in the gaps but nothing will make up for what he and they have missed over the years including his incredible grandchildren.
The melanoma diagnosis came after a visit to the GP when a mole on his back started bleeding and he was sent urgently to have it investigated. David faced all of his treatment and operations with dignity and hope. David did not fall into the category of a stereotypical melanoma statistic. He wasn’t a sun worshipper, he wasn’t a fair, blue eyed person. In fact we believe the damage was done on a cloudy day.
David would be so proud to see what has been achieved in his name and the ongoing exposure that is now in the public domain hoping to bring awareness to this awful disease which is still on the increase”.
As leaders in prevention, innovation and collaboration, Skcin are delighted to join forces with Map My Mole in a powerful partnership to make the early detection and diagnosis of skin cancer more accessible than ever across the UK. By combining Skcin’s trusted, award winning MASCED PRO education programme with Map My Mole’s fast, innovative mole-checking service, we’re setting a new standard for collaboration between charities and digital health innovators — delivering life-saving education, access, and action at scale. Read the full press release here.
To learn more and for an exclusive partnership discount on clinic set-up fees visit: https://pro.masced.uk/map-my-mole/info.htm
Skcin are proud to partner with online skincare and beauty retailer Face the Future, as their official charity partner. The collaboration underpins Face the Future’s commitment to supporting their community at every stage of their self-care journey, and importantly that includes protecting skin from one of the most preventable causes of skin damage and disease: the sun, via their ongoing ‘365 Days Of SPF’ campaign. Face the Future’s ongoing partnership with Skcin will further highlight and reinforce the charity’s important work to date, and Face the Future customers will be able to donate at checkout, as well as take part in some exciting fundraising activities (to be revealed) from Autumn 2025.
Skcin are proud to partner with National roofing merchant SIG Roofing, to raise the roof on sun safety, skin cancer prevention and early detection – via our national Sun Safe Workplaces accreditation programme. SIG Roofing employs staff that work outdoors in their yards all day across 107 branches nationwide, and they engage daily with roofers, who spend long periods of time exposed to UV. The partnership highlights their commitment to preventing occupational skin cancer among employees and raising vital awareness across the roofing industry.
Skcin proudly partnered with the UK’s #1 professional skin care brand Dermalogica in 2021 and 2022. Dermalogica supported Skcin by funding all 185+ of their Skin Therapist employees in the UK & Ireland to undertake our MASCED (Melanoma and Skin Cancer Early Detection) training, as well as offering funding for the course to all 5,000+ of their salon partners and skin therapists. Dermalogica remain keen supporters of the charity and continue to support their Therapist employees with access to this vital training.
Skcin are delighted to work in partnersip with globally renowned beauty salon and spa exclusive professional skincare brand Guinot. Guinot have supported Skcin by investing in the training of all their expert tharpists across the UK and Ireland with our MASCED (Melanoma and Skin Cancer Early Detection) Training programme, showing an ongoing commitment to providing quality training to promote their clients’ skin health and wellbeing.
Skcin partnered with quality sunscreen manufacturers Deb Group for many years before the company became part of SC Johnson Professional in 2015. We remain committed to working together, providing quality, high factor sunscreen cartridges, dispensers and bespoke branded sunboards via our Sun Safe Schools national accreditation programme.
SKCIN are delighted to have the support of fellow charity Melanoma UK who have funded a number of our award winning MASCED and MASCED PRO training courses. These accredited courses, developed by SKCIN are made available to Melanoma UK’s ambassadors, professionals, and partners, equipping them with essential knowledge to identify the early signs of melanoma and non-melanoma and skin cancer.
Skcin are grateful of the ongoing support provided by Bristol Myers Squibb who have donated various amounts to help us deliver numerous projects over many years.
Skcin is grateful for the ongoing support from Regeneron, whose charitable donations since 2024 have enabled us to deliver a wide range of projects that advance our mission—an impact we deeply value.
